Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Decreases Escherichia coli O126:H45 - : 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one {Luteolin} |
👶
Extensive impact of non-antibiotic drugs on human gut bacteria. Nature (Nature ) Vol: 555 Issue 7698 Pages: 623-628 Pub: 2018 Mar 29 Epub: 2018 Mar 19 Authors Maier L , Pruteanu M , Kuhn M , Zeller G , Telzerow A , Anderson EE , Brochado AR , Fernandez KC , Dose H , Mori H , Patil KR , Bork P , Typas A , Publication Publication |
| Decreases Escherichia coli O126:H45 - : 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one {Luteolin} |
👶
Therapeutic administration of Luteolin protects against Escherichia coli-derived Lipopolysaccharide-triggered inflammatory response and oxidative injury. Acta tropica (Acta Trop ) Vol: 255 Issue Pages: 107236 Pub: 2024 Jul Epub: 2024 Apr 29 Authors Shaukat A , Rajput SA , Ali M , Shukat R , Hanif S , Hassan M , Fouad D , Ataya FS , Shaukat I , Yousaf A , Shaukat S , Su RW , Publication |
| Decreases Escherichia coli O126:H45 - : 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one {Luteolin} |
👶
Dietary flavonoid luteolin attenuates uropathogenic Escherichia. Coli invasion of the urinary bladder. BioFactors (Oxford, England) (Biofactors ) Vol: 42 Issue 6 Pages: 674-685 Pub: 2016 Nov 12 Epub: 2016 Jul 25 Authors Shen XF , Teng Y , Sha KH , Wang XY , Yang XL , Guo XJ , Ren LB , Wang XY , Li J , Huang N , Publication |
| Decreases Escherichia coli O126:H45 - : 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one {Luteolin} |
👶
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents. European journal of medicinal chemistry (Eur J Med Chem ) Vol: 44 Issue 2 Pages: 908-14 Pub: 2009 Feb Epub: 2008 Jan 25 Authors Lv PC , Li HQ , Xue JY , Shi L , Zhu HL , Publication |
| Decreases Escherichia coli O126:H45 - : 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one {Luteolin} |
👶
Development of Luteolin-Loaded Calcium Alginate and Gum Tragacanth Blend Microbeads for Oral Delivery: In Vitro Characterization, Antioxidant, Antimicrobial, and Anticancer Activity Against Colon Cancer Cell Line (HT-29). Assay and drug development technologies (Assay Drug Dev Technol ) Vol: Issue Pages: Pub: 2025 Apr 4 Epub: 2025 Apr 4 Authors Zafar A , Alsaidan OA , Mujtaba MA , Sultana S , Publication |
